<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>imipridones ONC201/ONC206 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/imipridones-onc201-onc206/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 12:46:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>imipridones ONC201/ONC206 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Triple Therapy Demonstrates Potential to Inhibit Glioblastoma Progression and Prolong Survival in Preclinical Research</title>
		<link>https://bioengineer.org/triple-therapy-demonstrates-potential-to-inhibit-glioblastoma-progression-and-prolong-survival-in-preclinical-research/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 04 Apr 2025 18:27:07 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[glioblastoma combination therapy]]></category>
		<category><![CDATA[imipridones ONC201/ONC206]]></category>
		<category><![CDATA[MGMT suppression]]></category>
		<category><![CDATA[preclinical cancer research]]></category>
		<category><![CDATA[prolonged survival in glioblastoma]]></category>
		<guid isPermaLink="false">https://bioengineer.org/triple-therapy-demonstrates-potential-to-inhibit-glioblastoma-progression-and-prolong-survival-in-preclinical-research/</guid>

					<description><![CDATA[Researchers are continuously on the lookout for innovative treatment strategies for glioblastoma, a notoriously aggressive brain cancer. Recently, an exciting preclinical study published in the esteemed journal Oncotarget explored the combination of imipridones—specifically, ONC201 and its analog ONC206—with traditional therapies like radiation (RT) and temozolomide (TMZ). The research team, led by Brown University’s Lanlan Zhou [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">240080</post-id>	</item>
	</channel>
</rss>
